Report

Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in β Cells

See allHide authors and affiliations

Science  14 May 1999:
Vol. 284, Issue 5417, pp. 1183-1187
DOI: 10.1126/science.284.5417.1183

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Glutamic acid decarboxylase (GAD) is a pancreatic β cell autoantigen in humans and nonobese diabetic (NOD) mice. β Cell–specific suppression of GAD expression in two lines of antisense GAD transgenic NOD mice prevented autoimmune diabetes, whereas persistent GAD expression in the β cells in the other four lines of antisense GAD transgenic NOD mice resulted in diabetes, similar to that seen in transgene-negative NOD mice. Complete suppression of β cell GAD expression blocked the generation of diabetogenic T cells and protected islet grafts from autoimmune injury. Thus, β cell–specific GAD expression is required for the development of autoimmune diabetes in NOD mice, and modulation of GAD might, therefore, have therapeutic value in type 1 diabetes.

  • * To whom correspondence should be addressed. E-mail: yoon{at}ucalgary.ca

View Full Text